COHEN GLOBAL LIMITED
Company overview
- Incorporation date
- 19 February 2020
- Company type
- Private limited company
- Jurisdiction
- England/Wales
- Can file
- Yes
Insolvency notices
-
2 October 2026
Winding-up petition filed
Read the notice →
Contains data from The Gazette, published under the Open Government Licence v3.0.
What the records show
COHEN GLOBAL LIMITED is a private limited company incorporated on 19 February 2020, with its registered office in London. Companies House lists its business as manufacture of pharmaceutical preparations. Its most recent accounts were made up to 31 December 2025.
On 2 October 2026 The Gazette published a notice headed “Winding-up petition filed”.
In the 12 months before its first insolvency notice, Companies House recorded a change of registered office on 11 May 2026 and accounts filed on 7 April 2026. It has 1 serving director.
A winding-up petition asks a court to liquidate the company. A creditor can present one if they are owed £750 or more and can show the company cannot pay; the court decides at a hearing, and a petition can be dismissed. Source
Drawn only from the company's Gazette notices and its Companies House record. It records what was filed and published, not why.
Registered office address
C/O Baker Friend Ltd 1st Floor, 12 David Mews, Marylebone, London, W1U 6EG, England
Industry classification (SIC codes)
Officers & directors (1)
COHEN, Daniel
Director
Appointed: 19 February 2020
Recent filing history (19)
Confirmation statement made on 18 February 2026 with updates
Confirmation statement • Form CS01
Registered office address changed from 71-75 Shelton Street London WC2H 9JQ England to C/O Baker Friend Ltd 1st Floor, 12 David Mews Marylebone London W1U 6EG on 11 May 2026
Address • Form AD01
Total exemption full accounts made up to 31 December 2025
Accounts • Form AA
Registered office address changed from 71-75 Shelton Street Covent Garden London WC2H 9JQ United Kingdom to 71-75 Shelton Street London WC2H 9JQ on 5 March 2026
Address • Form AD01
Director's details changed for Mr Daniel Cohen on 5 March 2026
Officers • Form CH01
Registered office address changed from 32-33 Gosfield Street London W1W 6HL England to 71-75 Shelton Street Covent Garden London WC2H 9JQ on 5 March 2026
Address • Form AD01
Total exemption full accounts made up to 31 December 2024
Accounts • Form AA
Confirmation statement made on 18 February 2025 with no updates
Confirmation statement • Form CS01
Total exemption full accounts made up to 31 December 2023
Accounts • Form AA
Confirmation statement made on 18 February 2024 with no updates
Confirmation statement • Form CS01
Total exemption full accounts made up to 31 December 2022
Accounts • Form AA
Confirmation statement made on 18 February 2023 with updates
Confirmation statement • Form CS01
Notification of Radella Pharmaceuticals Llc as a person with significant control on 14 February 2023
Persons with significant control • Form PSC02
Total exemption full accounts made up to 31 December 2021
Accounts • Form AA
Confirmation statement made on 18 February 2022 with no updates
Confirmation statement • Form CS01
Persons with significant control (2)
Radella Pharmaceuticals Llc
Corporate entity
Notified: 14 February 2023
Mr Daniel Cohen
Individual
Notified: 19 February 2020
Is your website working as hard as your Companies House record?
Get a free website audit from an SEO consultant with 27 years' experience.
Get free auditFiling status
Accounts
Next due: 30 September 2027
Confirmation statement
Next due: 4 March 2027